首页 | 本学科首页   官方微博 | 高级检索  
     


Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B
Authors:R. Yang  Y. Zhao  X. Wang  J. Sun  J. Jin  D. Wu  R. Charnigo  A. O'Brien  Z. Zhong  P. Rendo
Affiliation:1. Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, , Tianjin, China;2. Peking Union Medical College Hospital, , Beijing, China;3. Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, , Shanghai, China;4. Nanfang Hospital, Southern Medical University, , Guangzhou, China;5. The First Affiliated Hospital of Medical School of Zhejiang University, , Hangzhou, China;6. The First Affiliated Hospital of Soochow University, , Suzhou, China;7. Pfizer Inc, , Collegeville, PA, USA;8. Pfizer Inc, , Beijing, China
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号